S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
Log in

TSE:OGI - ORGANIGRAM-TS Stock Price, Forecast & News

C$3.33
-0.19 (-5.40 %)
(As of 02/24/2020 04:00 PM ET)
Today's Range
C$3.27
Now: C$3.33
C$3.47
50-Day Range
C$2.61
MA: C$3.36
C$4.41
52-Week Range
C$2.47
Now: C$3.33
C$11.30
Volume978,848 shs
Average Volume1.79 million shs
Market CapitalizationC$544.76 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
OrganiGram Holdings Inc., through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders. OrganiGram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone844-644-4726

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$93.13 million
Cash FlowC$0.19 per share
Book ValueC$2.11 per share

Profitability

Miscellaneous

Employees622
Market CapC$544.76 million
Next Earnings Date4/20/2020 (Estimated)
OptionableOptionable

Receive OGI News and Ratings via Email

Sign-up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.


ORGANIGRAM-TS (TSE:OGI) Frequently Asked Questions

What is ORGANIGRAM-TS's stock symbol?

ORGANIGRAM-TS trades on the Toronto Stock Exchange (TSX) under the ticker symbol "OGI."

How were ORGANIGRAM-TS's earnings last quarter?

ORGANIGRAM-TS (TSE:OGI) announced its earnings results on Tuesday, January, 14th. The company reported ($0.02) EPS for the quarter, beating analysts' consensus estimates of ($0.04) by $0.02. The business had revenue of $25.15 million for the quarter, compared to the consensus estimate of $19.26 million. View ORGANIGRAM-TS's Earnings History.

When is ORGANIGRAM-TS's next earnings date?

ORGANIGRAM-TS is scheduled to release their next quarterly earnings announcement on Monday, April 20th 2020. View Earnings Estimates for ORGANIGRAM-TS.

What is the consensus analysts' recommendation for ORGANIGRAM-TS?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ORGANIGRAM-TS in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for ORGANIGRAM-TS.

Has ORGANIGRAM-TS been receiving favorable news coverage?

Media coverage about OGI stock has been trending very negative recently, InfoTrie reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. ORGANIGRAM-TS earned a coverage optimism score of -3.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for ORGANIGRAM-TS.

Who are some of ORGANIGRAM-TS's key competitors?

What other stocks do shareholders of ORGANIGRAM-TS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ORGANIGRAM-TS investors own include Aurora Cannabis (ACB), Cassava Sciences (SAVA), Canopy Growth (WEED), AVITA MED LTD/S (RCEL), Exelixis (EXEL), NeoGenomics (NEO), Cosan (CZZ), JPMorgan Chase & Co. (JPM), Nokia Oyj (NOK) and PagSeguro Digital (PAGS).

Who are ORGANIGRAM-TS's key executives?

ORGANIGRAM-TS's management team includes the folowing people:
  • Mr. Greg Engel, CEO & Director (Age 54)
  • Mr. Paolo De Luca C.A., C.F.A, Chief Financial Officer (Age 46)
  • Mr. Jeff Purcell, VP - Operations
  • Mr. Timothy Emberg, Sr. VP of Sales & Commercial Operations
  • Mr. Peter R. Hanson, Director of Fin.

How do I buy shares of ORGANIGRAM-TS?

Shares of OGI and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is ORGANIGRAM-TS's stock price today?

One share of OGI stock can currently be purchased for approximately C$3.33.

How big of a company is ORGANIGRAM-TS?

ORGANIGRAM-TS has a market capitalization of C$544.76 million and generates C$93.13 million in revenue each year. ORGANIGRAM-TS employs 622 workers across the globe.View Additional Information About ORGANIGRAM-TS.

What is ORGANIGRAM-TS's official website?

The official website for ORGANIGRAM-TS is http://www.organigram.ca/.

How can I contact ORGANIGRAM-TS?

The company can be reached via phone at 844-644-4726.


MarketBeat Community Rating for ORGANIGRAM-TS (TSE OGI)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  9 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  16
MarketBeat's community ratings are surveys of what our community members think about ORGANIGRAM-TS and other stocks. Vote "Outperform" if you believe OGI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OGI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel